New Hyde Park, NYNCT06613568Now EnrollingIRB Ready

End Stage Kidney Disease Clinical Trial in New Hyde Park, NY

Access cutting-edge end stage kidney disease treatment through this clinical trial at a research site in New Hyde Park. Study-provided care at no cost to qualified participants.

Sponsored by Diality Inc.

Quick Self-Assessment

See if you qualify for this New Hyde Park location

Preparing your pre-screening questions…

Expert Care in New Hyde Park

Access end stage kidney disease specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related end stage kidney disease treatment provided free

Apply for This New Hyde Park Location

Check if you qualify for this end stage kidney disease clinical trial in New Hyde Park, NY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to New Hyde Park

    Convenient for NY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit New Hyde Park site if eligible
  4. 4Begin participation

About This End Stage Kidney Disease Study in New Hyde Park

The purpose of this study is to evaluate the safety and efficacy of the Moda-flx Hemodialysis System™ when used Under Professional Care Settings by trained individuals and At Home by trained Participants and Care Partners

Sponsor: Diality Inc.

Who Can Participate

Inclusion Criteria

Are between 18 and 80 years of age and Care Partner is at least 18 years of age at the time of signing consent.
Have a diagnosis of end stage kidney disease (ESKD) adequately treated by maintenance dialysis (defined as achieving a spKt/V ≥ 1.2 OR stdKt/V ≥ 2.1) and be deemed stable by their treating nephrologist prior to the end of the Screening Period
Have a well-functioning and stable vascular access (tunneled central venous catheter arteriovenous fistula, or graft) that allows a blood flow of at least 300 ml/min prior to the end of Screening
Can successfully complete a Skills and Comprehension Assessment with a Care Partner prior to the completion of the Training Period.

Exclusion Criteria

Hgb level of \< 9 g/dL at Screening
Symptomatic intradialytic hypotension requiring medical intervention (ultrafiltration turned off, bolus of fluid) in at least two treatments during the Run-In period defined as:
Persistent pre-dialysis sitting SBP \< 100 mmHg despite medical therapy,
Nadir intradialytic Systolic Blood Pressure (SBP) \< 90 mmHg, if Subject's pre-HD SBP \< 160 mmHg
Nadir intradialytic SBP \< 100 mmHg if Subject's pre-HD SBP ≥ 160 mmHg
Documented history of non-adherence to dialysis therapy that would prevent successful completion of the study
Participant had an average ultrafiltration rate \> 13 mL/kg/hour during the last 2 weeks prior to Screening, per medical records.
Had a significant cardiovascular adverse event within the last 90 days prior to Screening.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in New Hyde Park?

Yes, this clinical trial (NCT06613568) has an active research site in New Hyde Park, NY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

End Stage Kidney Disease Treatment Options in New Hyde Park, NY

If you're searching for end stage kidney disease treatment options in New Hyde Park, NY, this clinical trial (NCT06613568) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our New Hyde Park research site is actively enrolling participants for this clinical trial. You'll receive care from experienced end stage kidney disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all end stage kidney disease clinical trials near you to find additional studies recruiting in your area.

More Ankylosing Spondylitis Trials in New Hyde Park, NY

See all ankylosing spondylitis clinical trials recruiting in New Hyde Park — not just this study.

Browse Ankylosing Spondylitis Trials in New Hyde Park →

Browse More Trials by Condition

Ankylosing Spondylitis TrialsAll Conditions →

Ready to Join in New Hyde Park?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · New Hyde Park, NY